These transgenic mice carry an R306C transcriptional repression domain (TRD) mutant form of human MECP2, and are tagged with EGFP. They have been useful in studies of Rett Syndrome (RTT) and MECP2 duplication syndrome.
Huda Zoghbi, Baylor College of Medicine
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Inserted expressed sequence, Humanized sequence) |
MECP2 (methyl CpG binding protein 2) is an X-linked transcriptional repressor that binds to methylated CpG dinucleotides. Loss of function causes the progressive neurological disorder Rett Syndrome (RTT). Conversely, duplication or triplication of the chromosomal region causes an equally wide-ranging progressive neurological disorder, MECP2 duplication syndrome, whose features overlap somewhat with RTT.
This transgenic strain expresses full-length human MECP2 carrying an R306C mutation in the transcriptional repression domain (TRD) fused to EGFP. Immunofluorescent methods using anti-MECP2 and anti-GFP antibodies reveal expression patterns throughout the brain that parallel those of the endogenous gene. Transgene expression levels are similar to those of the endogenous X-linked mouse gene.
Hemizygous mice demonstrate no overt phenotype (normal lifespan, body weight, and brain size) on their own, but when put on a Mecp2-/y background (see Stock No. 005439), they model Rett syndrome with a milder phenotype than the Mecp2 null mice. Compound mutant mice have a shortened lifespan with 50% lethality at 18 weeks (as compared to 11 weeks in Mecp2 null mice) and have smaller brains, motor dysfunction, learning disabilities, increased anxiety, and hypoactivity.
PAC (PAC671D9), containing the entire human MECP2 locus and its essential regulatory elements, was C-terminally tagged with EGFP. An R306C (CGC to TGC) missense mutation in the transcriptional repression domain (TRD) of exon 4 was also introduced. The 99kb PAC was linearized and separated from the backbone by pulse field gel electrophoresis before injection into FVB single cell zygotes. This strain was maintained on an FVB background by the donating lab.
Expressed Gene | GFP, Green Fluorescent Protein, |
---|---|
Site of Expression | MECP2 and GFP are expressed in the brain. |
Allele Name | transgene insertion 1, Huda Y Zoghbi |
---|---|
Allele Type | Transgenic (Inserted expressed sequence, Humanized sequence) |
Allele Synonym(s) | MECP2R306C-EGFPTg; R306G Tg |
Gene Symbol and Name | Tg(MECP2*R306C/EGFP)1Hzo, transgene insertion 1, Huda Y Zoghbi |
Gene Synonym(s) | |
Promoter | MECP2, methyl-CpG binding protein 2, human |
Expressed Gene | GFP, Green Fluorescent Protein, |
Site of Expression | MECP2 and GFP are expressed in the brain. |
Strain of Origin | FVB/N |
Chromosome | UN |
Molecular Note | A human PAC (PAC671D9) containing only the MECP2 locus and regulatory elements was modified to introduce a R306C (CGC to TCG) missense mutation in the transcriptional repression domain (TRD) of exon 4 and a C-terminal GFP tag. Expression of the transgene parallels that of endogenous MECP2 in the brain. |
Hemizygotes are viable and fertile.
When using the FVB/N-Tg(MECP2*R306C/EGFP)1Hzo/J mouse strain in a publication, please cite the originating article(s) and include JAX stock #026044 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Hemizygous or non carrier for Tg(MECP2*R306C/EGFP)1Hzo |
Frozen Mouse Embryo | FVB/N-Tg(MECP2*R306C/EGFP)1Hzo/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(MECP2*R306C/EGFP)1Hzo/J Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | FVB/N-Tg(MECP2*R306C/EGFP)1Hzo/J Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | FVB/N-Tg(MECP2*R306C/EGFP)1Hzo/J Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.